Non-invasive blood pressure measurement with ClearSight during interhospital intensive care transfers: Comparison with arterial reference measurement

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037248

Enrollment

Registered

2025-06-23

Start date

2025-09-15

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood pressure monitoring

Interventions

Group 1: In addition to the arterial catheter already in place, the ClearSight system (Edwards Lifesciences) for non-invasive, continuous blood pressure measurement is applied to all patients requirin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Existing consent for participation in the study Intensive care patients with established invasive blood pressure measurement Transfer with the IHT Marburg

Exclusion criteria

Exclusion criteria: No consent to participate in the study No intensive care patients with established invasive blood pressure measurement No transfer with the IHT Marburg

Design outcomes

Primary

Measure	Time frame
Agreement of systolic, diastolic and mean blood pressure values between ClearSight and arterial measurement	—

Secondary

Measure	Time frame
Technical feasibility, signal stability, data loss rate, analysis of extended haemodynamic parameters	—

Countries

Germany

Contacts

Public ContactBenjamin Vojnar

Klinik für Anästhesie und Intensivtherapie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg

vojnar@med.uni-marburg.de+49 (0)6421 58 61123

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026